Efficacy and safety of Aclidinium The ATTAIN Study
{"Image DocumentName": "Efficacy and safety of Aclidinium The ATTAIN Study", "Image ImageDescription": "N = 824 FEV1 = 1.5 L DB,R, PC. 24 weeks 2 doses versus placebo. No difference in side effects versus placebo. TDI was also improved. Jones P et al Eur Respir J 2012 e published March 22.", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}